Akari Therapeutics
AKTX
12 hedge funds and large institutions have $2.93M invested in Akari Therapeutics in 2020 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
16% more capital invested
Capital invested by funds: $2.54M → $2.93M (+$396K)
0% more funds holding
Funds holding: 12 → 12 (0)
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$357K |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
+$18K |
| 3 |
TC
Truvestments Capital
Sarasota,
Florida
|
+$4.16K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$2.77K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
-$88K |
| 2 |
WS
Wedbush Securities
Los Angeles,
California
|
-$55K |
| 3 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$18K |
| 4 |
Renaissance Technologies
New York
|
-$1.39K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
NMC
1
NEA Management Company
Timonium,
Maryland
| $837K | – | – | – |
|
|
OFW
2
Omnia Family Wealth
Aventura,
Florida
| $724K | – | – | – |
|
|
UAS
3
United Asset Strategies
Garden City,
New York
| $530K | – | – | – |
|
|
ECM
4
Endurant Capital Management
San Mateo,
California
| $382K | +$357K | +258 | New |
|
|
5
Renaissance Technologies
New York
| $199K | -$1.39K | -1 | -0.7% |
|
|
HP
6
Hikari Power
Tokyo,
Japan
| $166K | – | – | – |
|
|
7
HighTower Advisors
Chicago,
Illinois
| $49K | +$18K | +13 | +65% |
|
8
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $22K | – | – | – |
|
9
Morgan Stanley
New York
| $11K | – | – | – |
|
10
Bank of America
Charlotte,
North Carolina
| $6K | – | – | – |
|
|
11
UBS Group
Zurich,
Switzerland
| $3K | +$2.77K | +2 | New |
|
|
TC
12
Truvestments Capital
Sarasota,
Florida
| $3K | +$4.16K | +3 | New |
|
|
HF
13
HRT Financial
New York
| – | -$88K | -63 | Closed |
|
|
WS
14
Wedbush Securities
Los Angeles,
California
| – | -$55K | -39 | Closed |
|
|
15
Commonwealth Equity Services
Waltham,
Massachusetts
| – | -$18K | -14 | Closed |
|
AKTX Hedge Fund Activity: Q4 2020 in Review
12 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Akari Therapeutics (AKTX) for Q4 2020, worth a combined $2.93M — up 16% from $2.54M a quarter earlier.
Fund positioning in AKTX was balanced in Q4 2020: 3 funds opened new positions, 3 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Endurant Capital Management, opening a new position worth an estimated $357K. The largest seller was HRT Financial, exiting entirely with an estimated $88K sold.
- 12 institutional investors held Akari Therapeutics (AKTX) as of Q4 2020, unchanged from Q3 2020.
- Funds reported $2.93M of Akari Therapeutics stock for Q4 2020, up 16% quarter-over-quarter.
- 3 funds opened new Akari Therapeutics positions in Q4 2020 and 3 closed out, a net change of 0 holders.
- The largest Akari Therapeutics buyer in Q4 2020 was Endurant Capital Management, an estimated $357K added.
- The largest Akari Therapeutics seller in Q4 2020 was HRT Financial, an estimated $88K sold.
Based on aggregated 13F filings for Q4 2020.